Kidney & Renal Cancer Clinical Trials.
There are over 600 live clinical trials for cancer in the UK today. Let us help you find the right trial for you.
RareCan is the only organisation in the UK that specialises in finding clinical trials for patients with rare cancer.
Please fill in the form to get started.
RareCan has over 50 members with kidney & renal cancers
RareCan has over 50 members with kidney & renal cancer
Prefer to do things by phone?
If you’d prefer to register by telephone, you can request a call-back by giving us your name and phone number below.
What is RareCan?
RareCan is a range of products and services that help you:
- Understand clinical trials and when they might an option for you
- Find trials that might be suitable for you now or in the future
- Get more detailed analysis of your tumour genetics to help identify potentially suitable clinical trials
- Understand genetics reports you have already had produced elsewhere and use them to find UK clinical trials
Book a free discovery call to find out if joining RareCan is right for you.
RareCan: Clinical Trial Service
£150 per year
- 1-2-1 telephone and email support from our experienced team
- A personalised report on potentially suitable clinical trials
- Updates to the report as new trials start or your situation changes
- Support to understand and discuss the report with your clinical team
RareCan: Insight
Price varies
- A range of high-precision multi-biomarker tests from blood or tissue samples that provide a detailed genomic profile of your tumour genetics
- A summary produced from an existing genetic report such as Guardent 360 or Foundation One to help you and your clinical team understand and use your existing report
Kidney Cancer UK
For more than two decades, Kidney Cancer UK has been the country’s leading charity dedicated to improving the lives of those affected by kidney cancer. The organisation works to lessen the impact of the disease by raising awareness, providing trusted information and support to patients and carers, and funding vital research into its causes, prevention, and treatment across the UK.
Kidney / Renal Cell Cancer Information
What is Kidney Cancer / Renal Cell Cancer?
Kidney cancer (also known as renal cancer) occurs when cells in one or both kidneys grow out of control and form a tumour. The most common subtype in adults is renal cell carcinoma, which develops in the lining of tiny tubes inside the kidney. Other, rarer forms include cancers of the renal pelvis or ureter. Generally, kidney cancer starts in just one kidney and may spread if untreated.
How rare is it?
In the UK, kidney cancer accounts for about 4 % of all new cancer cases, making it the 6th most common cancer. Each year there are roughly 13,800 new diagnoses across the country. Although not amongst the very rarest cancers, it remains much less frequent than cancers such as breast, lung or bowel.
Who does it affect?
Kidney cancer becomes more common with age and is rarely seen in younger adults. Around three-quarters of cases are diagnosed in people aged 60 or over. Men are at higher risk than women.
RareCan has over 3,000 members, here’s what some of them say.
The voices and experiences from our RareCan members, shared to help others on their own cancer journey.
“I joined RareCan to support research into my extremely rare and highly aggressive subtype of uterine cancer.”
— Lindy
RareCan Member
“I joined RareCan to get action and support and research on rare cancers”
— Steve
RareCan Member
“I joined RareCan because they have the solution to the challenges faced within rare cancer research.”
— Dave
RareCan Member
“I joined RareCan as it may help other people in the future.”
— Wayne
RareCan Member
“If my husband was alive today, he would encourage people to take part in research as you never know if you will ever need it in the future.”